Nearly 1 in 6 Children on GLP-1 Drugs Develop Nutritional Deficiencies

As GLP-1 medications extend their reach into pediatric medicine, a troubling pattern has emerged: nearly one in six children treated for obesity with these drugs developed nutritional deficiencies within a year. The finding invites a deeper reckoning with what it means to intervene in a child's still-forming body, where growth and nourishment are not incidental concerns but foundational ones. The promise of weight loss, real and meaningful as it is, now sits alongside a quieter risk — one measured not in pounds but in the slow, invisible work of vitamins and minerals that build bones, brains,